Effect of p38 MAP kinase on cellular events during ischemia and reperfusion: possible therapy.
Maulik
Nilanjana
N
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007093:Imidazoles / Q000008:administration & dosage; D032383:Myocytes, Cardiac / Q000378:metabolism* / Q000473:pathology; D011725:Pyridines / Q000008:administration & dosage; D051381:Rats; D015427:Reperfusion Injury / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D048051:p38 Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*
D004791:Enzyme Inhibitors; D007093:Imidazoles; D011725:Pyridines; D048051:p38 Mitogen-Activated Protein Kinases; C093642:SB 203580